Epycure

About Epycure

Epycure is a French direct-to-consumer company operating in the wellness sector, specializing in personalized and natural food supplements. Founded in 2019 by Paul-Etienne Jacob, Angélique d'Esclaibes, and Marc Menasé, the company aims to modernize the food supplement market by emphasizing transparency, natural ingredients, and personalization. The founding was driven by the co-founders' personal experiences and observations of a market saturated with under-dosed formulas and artificial ingredients. Paul-Etienne Jacob, influenced by his father's passion for scientific research and his own background in finance, sought to create a more transparent and effective solution. Angélique d'Esclaibes was motivated by her own health journey to develop products with tangible benefits.

The company's primary business model revolves around a subscription-based service for tailor-made vitamin and mineral programs. Clients begin by completing an online questionnaire about their lifestyle and wellness goals, after which an algorithm generates a personalized supplement formula. This direct-to-consumer approach targets a digitally native, urban demographic, providing monthly home deliveries. In addition to its core personalized offering, Epycure has expanded its product line to include standardized items such as gummies, powders, and capsules targeting specific needs like sleep, stress, skin health, and sports performance. These products are sold through its website and have expanded into retail channels, including Parisian department stores like Le Bon Marché and Relay stores in Paris airports.

Epycure's product formulations are developed in-house, focusing on natural, vegan, gluten-free, and GMO-free ingredients, with manufacturing taking place in France to ensure quality and traceability. The company has received B Corp certification, highlighting its commitment to social and environmental standards. Epycure secured a €2.5 million seed funding round in 2021, led by the venture studio Founders Future, to fuel its research and development and support European expansion.